Date published: 2026-4-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Alix Inhibitors

Alix, also known as ALG-2-interacting protein X, is a multifunctional protein involved in various cellular processes, including endosomal sorting, membrane trafficking, and cell signaling. As a component of the endosomal sorting complex required for transport (ESCRT) machinery, Alix plays a crucial role in the formation of multivesicular bodies (MVBs) and the sorting of ubiquitinated cargo proteins for degradation in lysosomes. Additionally, Alix interacts with numerous cellular proteins and regulates diverse signaling pathways implicated in cell proliferation, apoptosis, and cytoskeletal dynamics. Through its interactions with ESCRT proteins, Alix participates in the abscission phase of cytokinesis, facilitating the final separation of daughter cells during cell division. Moreover, Alix is involved in the repair of damaged DNA, contributing to genome stability and cellular integrity.

Inhibition of Alix function can occur through various mechanisms that disrupt its interactions with binding partners or interfere with its cellular localization and activity. One approach to inhibiting Alix involves the disruption of its interaction with ESCRT proteins, thereby impairing its function in endosomal sorting and membrane trafficking. This can be achieved through the use of small molecule inhibitors or peptides that target the Alix binding interface or disrupt protein-protein interactions critical for ESCRT assembly and function. Additionally, inhibition of Alix activity can be achieved through modulation of its post-translational modifications, such as phosphorylation or ubiquitination, which regulate its stability and subcellular localization. Furthermore, targeting upstream regulators or downstream effectors of Alix-mediated signaling pathways may also represent strategies for inhibiting Alix function and modulating cellular processes in which it is involved. Overall, understanding the mechanisms of Alix inhibition offers insights into strategies for targeting cellular processes dysregulated in various diseases.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$176.00
$426.00
43
(3)

Doxorubicin might down-regulate Alix expression in certain cancer cells, which could be part of its antitumor mechanism.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

This agent can suppress transcription, potentially leading to down-regulation of Alix.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$37.00
$152.00
11
(1)

5-FU might reduce Alix expression in certain cell types as a part of its mechanism to induce apoptosis.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

As an HDAC inhibitor, Suberoylanilide Hydroxamic Acid might down-regulate Alix expression by altering histone acetylation and transcriptional activity.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$58.00
$186.00
$94.00
21
(2)

This topoisomerase inhibitor can lead to decreased Alix expression in certain cell lines, potentially impacting apoptosis.

Tamoxifen

10540-29-1sc-208414
2.5 g
$272.00
18
(2)

As an estrogen receptor modulator, tamoxifen might down-regulate Alix expression in hormone-responsive cells.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

An antifolate and immunosuppressive, methotrexate might decrease Alix expression in certain cells, affecting cell survival.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

This proteasome inhibitor could potentially reduce Alix expression by affecting protein degradation pathways.

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

As a tyrosine kinase inhibitor, imatinib might down-regulate Alix in cells with certain oncogenic mutations.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

This topoisomerase II inhibitor might decrease Alix expression as a part of its mechanism to induce DNA damage and apoptosis.